Diseases, Conditions, Syndromes

EU drug watchdog approves first RSV infant, elderly vaccine

Europe's drug watchdog on Friday approved the world's first vaccine for infants and those over 60 against the Respiratory Syncytial Virus, a major cause of hospitalization on the continent, the Amsterdam-based agency said.

Diseases, Conditions, Syndromes

The long-awaited RSV vaccine

Two vaccines to protect against respiratory syncytial virus (RSV) are now available for those over age 60, but a vaccine to protect young children is still in development. "The Long-Awaited RSV Vaccine" provides an update ...

Immunology

COVID-19 vaccines produce antibody response in the nasal mucosa

Respiratory viruses are known for their ability to enter the body through the eyes, nose, or mouth. Our bodies know that too. The nasal cavity is well-equipped with sticky mucus that traps pathogens and serves as an important ...

page 15 from 40